Yousif Capital Management LLC Has $515,000 Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Yousif Capital Management LLC trimmed its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,810 shares of the company’s stock after selling 127 shares during the period. Yousif Capital Management LLC’s holdings in U.S. Physical Therapy were worth $515,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of USPH. State Street Corp boosted its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares during the last quarter. Copeland Capital Management LLC lifted its stake in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Southernsun Asset Management LLC lifted its stake in U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after purchasing an additional 52,062 shares during the last quarter. Penn Davis Mcfarland Inc. acquired a new stake in U.S. Physical Therapy in the 3rd quarter valued at about $2,552,000. Finally, Rockefeller Capital Management L.P. lifted its stake in U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares during the last quarter.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $86.85 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of 92.39, a P/E/G ratio of 3.61 and a beta of 1.48. The firm’s 50 day simple moving average is $89.88 and its 200 day simple moving average is $87.94. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63.

Insider Buying and Selling at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on USPH shares. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Finally, JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target on the stock. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.